RUBEDO LIFE SCIENCES
Rubedo Life Sciences mission is to treat age-related diseases to extend health-span targeting senescence and stem cells.
RUBEDO LIFE SCIENCES
Social Links:
Industry:
Biotechnology Health Care
Founded:
2018-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Website Url:
http://www.rubedolife.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
12 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Current Employees Featured
Founder
Investors List
The Longevity Fund
The Longevity Fund investment in Seed Round - Rubedo Life Sciences
Shanda Group
Shanda Group investment in Seed Round - Rubedo Life Sciences
Refactor Capital
Refactor Capital investment in Seed Round - Rubedo Life Sciences
Khosla Ventures
Khosla Ventures investment in Seed Round - Rubedo Life Sciences
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-01 | Rubedo Life Sciences Expands Leadership Team with Ali Siam as Chief Business Officer and Ofir Moreno, Ph.D., as SVP of Drug Discovery |
Official Site Inspections
http://www.rubedolife.com Semrush global rank: 5.62 M Semrush visits lastest month: 1.5 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Rubedo Life Sciences"
Home - Rubedo Life Sciences
Rubedo Life Sciences is the Premier Longevity Company. Rubedo discovers and develops medicines to keep you biologically young.See details»
Rubedo Life Sciences - Crunchbase Company Profile
Rubedo Life Sciences focuses on developing medicines that target the specific cells responsible for aging, known as pathologic cells. Rubedo Life Sciences successfully closed a $40 million Series A financing round led by Khosla …See details»
Rubedo Company Profile 2024: Valuation, Funding
Operator of a biopharmaceutical company intended to commercialize novel therapeutics that target and eliminate senescent cells.See details»
Rubedo Life Sciences - LinkedIn
Rubedo Life Sciences is a biopharmaceutical company developing a broad portfolio of innovative therapies engineered to target cells which drive chronic age-related diseases.See details»
Rubedo Life Sciences, Inc - VentureRadar
Website: https://www.rubedolife.com/ Develops medicines targeting the root causes of chronic diseases, focusing on longevity and extending health span by addressing aging-related …See details»
Rubedo Life Sciences - Overview, News & Similar companies
View Rubedo Life Sciences (www.rubedolife.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
With $40 million, Rubedo Life Sciences aims to clear …
Apr 19, 2024 · Now, Quarta is heading up a new start-up, Rubedo Life Sciences. The 27-person firm just brought in $40 million in a series A financing round co-led by Khosla Ventures and Ahren Innovation Capital. The start-up will develop …See details»
Rubedo Life Sciences - Craft
Rubedo Life Sciences is a biotech company that develops therapies extending senescent cells in a body. It offers treatments for age-related diseases such as Alzheimer’s, Cancer, Diabetes, or …See details»
Dr. Marco Quarta, Ph.D. - Co-Founder and CEO - YouTube
Sep 22, 2023 · Dr. Marco Quarta, Ph.D. is Co-Founder and CEO of Rubedo Life Sciences ( https://www.rubedolife.com/ ), a biopharmaceutical company developing a broad portfolio of innovative therapies...See details»
Rubedo Life Sciences - BIO International Convention | BIO
Jun 6, 2023 · Rubedo Life Sciences is a biopharmaceutical company developing a broad portfolio of innovative therapies engineered to target cells which drive chronic age-related diseases.See details»
Rubedo Life Sciences Announces European Expansion Ahead of …
Oct 23, 2024 · Rubedo Life Sciences is a biopharmaceutical company developing a broad portfolio of innovative therapies engineered to target cells which drive chronic age-related …See details»
Rubedo Life Sciences Closes $40M Series A Financing Led by …
Apr 22, 2024 · Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive age-related diseases, announced …See details»
Rubedo Life Sciences and Beiersdorf Announce Multi-Year
Apr 23, 2024 · Rubedo Life Sciences announced a multi-year strategic partnership with German multinational beauty company Beiersdorf AG to develop innovative skin care products that …See details»
Rubedo Life Sciences Closes $12M Seed Financing Led by Khosla …
Dec 3, 2020 · SUNNYVALE, Calif.-- ( BUSINESS WIRE )-- Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting …See details»
Rubedo Raises $40M Series A to Combat Age-Related Diseases
Apr 22, 2024 · Rubedo Life Sciences, a biopharmaceutical company focused on developing therapies for age-related diseases, has closed a $40 million Series A financing round. The …See details»
Rubedo Life Sciences Establishes Collaboration with Cedars-Sinai ...
Jun 1, 2021 · Rubedo Life Sciences is a biopharmaceutical company developing a broad portfolio of product candidates engineered to target senescent cells and other cell types which drive …See details»
Rubedo Life Sciences Closes $40M Series A Financing Led by …
SUNNYVALE, Calif., April 22, 2024 -- (BUSINESS WIRE)-- Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting …See details»
Rubedo Life Sciences Presents In Vivo Efficacy Data Targeting ...
Mar 20, 2023 · Rubedo is planning first-in-human studies in multiple skin indications driven by chronic inflammation and degenerative fibrosis.See details»
Rubedo Life Sciences Closes $12M Seed Financing Led by
Dec 3, 2020 · SUNNYVALE, Calif.-- ( BUSINESS WIRE )-- Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting …See details»
Rubedo Life Sciences Announces European Expansion Ahead of …
Oct 23, 2024 · (BUSINESS WIRE)-- Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive age …See details»